| Product Code: ETC7554252 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India solid tumor therapeutics market import shipments showed steady growth with a CAGR of 3.0% from 2020 to 2024. Furthermore, the market demonstrated a notable acceleration in growth between 2023 and 2024, with a growth rate of 26.5%. Overall, the market expanded consistently, with increasing momentum towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Solid Tumor Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Solid Tumor Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Solid Tumor Therapeutics Market - Industry Life Cycle |
3.4 India Solid Tumor Therapeutics Market - Porter's Five Forces |
3.5 India Solid Tumor Therapeutics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 India Solid Tumor Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 India Solid Tumor Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of solid tumors in India |
4.2.2 Growing adoption of targeted therapies for solid tumors |
4.2.3 Government initiatives to improve cancer care and treatment facilities |
4.3 Market Restraints |
4.3.1 High cost associated with solid tumor therapeutics |
4.3.2 Limited access to advanced treatment options in rural areas of India |
4.3.3 Stringent regulatory requirements for approval of new therapies |
5 India Solid Tumor Therapeutics Market Trends |
6 India Solid Tumor Therapeutics Market, By Types |
6.1 India Solid Tumor Therapeutics Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 India Solid Tumor Therapeutics Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 India Solid Tumor Therapeutics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 India Solid Tumor Therapeutics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.5 India Solid Tumor Therapeutics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 India Solid Tumor Therapeutics Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.7 India Solid Tumor Therapeutics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.8 India Solid Tumor Therapeutics Market Revenues & Volume, By Other Cancer Types, 2021- 2031F |
6.2 India Solid Tumor Therapeutics Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 India Solid Tumor Therapeutics Market Revenues & Volume, By Carboplatin, 2021- 2031F |
6.2.3 India Solid Tumor Therapeutics Market Revenues & Volume, By Cisplatin, 2021- 2031F |
6.2.4 India Solid Tumor Therapeutics Market Revenues & Volume, By Gemcitabine, 2021- 2031F |
6.2.5 India Solid Tumor Therapeutics Market Revenues & Volume, By Paclitaxel, 2021- 2031F |
6.2.6 India Solid Tumor Therapeutics Market Revenues & Volume, By Doxorubicin, 2021- 2031F |
6.2.7 India Solid Tumor Therapeutics Market Revenues & Volume, By Bevacizumab, 2021- 2031F |
7 India Solid Tumor Therapeutics Market Import-Export Trade Statistics |
7.1 India Solid Tumor Therapeutics Market Export to Major Countries |
7.2 India Solid Tumor Therapeutics Market Imports from Major Countries |
8 India Solid Tumor Therapeutics Market Key Performance Indicators |
8.1 Average survival rate of patients undergoing solid tumor therapeutics |
8.2 Number of clinical trials conducted for solid tumor treatments in India |
8.3 Adoption rate of precision medicine approaches in solid tumor treatment |
9 India Solid Tumor Therapeutics Market - Opportunity Assessment |
9.1 India Solid Tumor Therapeutics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 India Solid Tumor Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 India Solid Tumor Therapeutics Market - Competitive Landscape |
10.1 India Solid Tumor Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Solid Tumor Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here